Anti-USP13 monoclonal antibody

Pre-made anti-USP13 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to USP13/USP13 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T07584-Ab-1/ GM-Tg-hg-T07584-Ab-2Anti-Human USP13 monoclonal antibodyHuman
GM-Tg-rg-T07584-Ab-1/ GM-Tg-rg-T07584-Ab-2Anti-Rat USP13 monoclonal antibodyRat
GM-Tg-mg-T07584-Ab-1/ GM-Tg-mg-T07584-Ab-2Anti-Mouse USP13 monoclonal antibodyMouse
GM-Tg-cynog-T07584-Ab-1/ GM-Tg-cynog-T07584-Ab-2Anti-Cynomolgus/ Rhesus macaque USP13 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T07584-Ab-1/ GM-Tg-felg-T07584-Ab-2Anti-Feline USP13 monoclonal antibodyFeline
GM-Tg-cang-T07584-Ab-1/ GM-Tg-cang-T07584-Ab-2Anti-Canine USP13 monoclonal antibodyCanine
GM-Tg-bovg-T07584-Ab-1/ GM-Tg-bovg-T07584-Ab-2Anti-Bovine USP13 monoclonal antibodyBovine
GM-Tg-equg-T07584-Ab-1/ GM-Tg-equg-T07584-Ab-2Anti-Equine USP13 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T07584-Ab-1/ GM-Tg-hg-T07584-Ab-2; GM-Tg-rg-T07584-Ab-1/ GM-Tg-rg-T07584-Ab-2;
GM-Tg-mg-T07584-Ab-1/ GM-Tg-mg-T07584-Ab-2; GM-Tg-cynog-T07584-Ab-1/ GM-Tg-cynog-T07584-Ab-2;
GM-Tg-felg-T07584-Ab-1/ GM-Tg-felg-T07584-Ab-2; GM-Tg-cang-T07584-Ab-1/ GM-Tg-cang-T07584-Ab-2;
GM-Tg-bovg-T07584-Ab-1/ GM-Tg-bovg-T07584-Ab-2; GM-Tg-equg-T07584-Ab-1/ GM-Tg-equg-T07584-Ab-2
Products NameAnti-USP13 monoclonal antibody
Formatmab
Target NameUSP13
Protein Sub-locationIntrocelluar Protein
Category of antibodyTherapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-USP13 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-T07584-Ag-1Recombinant multi-species UBP13/ USP13/ ISOT3 protein
    ORF Viral VectorvGMLP003180human USP13 Lentivirus particle
    ORF Viral VectorpGMLP003180human USP13 Lentivirus plasmid
    ORF Viral VectorpGMAD000031mouse Usp13 Adenovirus plasmid
    ORF Viral VectorvGMAD000031mouse Usp13 Adenovirus particle


    Target information

    Target IDGM-T07584
    Target NameUSP13
    Gene ID8975,72607,310306,708624,478640,101091353,100141289,100065844
    Gene Symbol and Synonyms2700071E21Rik,IsoT-3,ISOT3,USP13
    Uniprot AccessionQ92995,E1BMF7
    Uniprot Entry NameUBP13_HUMAN,UBP13_BOVIN
    Protein Sub-locationIntrocelluar Protein
    CategoryTherapeutics Target
    DiseaseN/A
    Gene EnsemblENSG00000058056
    Target ClassificationN/A

    The target: USP13, gene name: USP13, also named as ISOT3, IsoT-3. Enables several functions, including BAT3 complex binding activity; chaperone binding activity; and cysteine-type peptidase activity. Involved in several processes, including maintenance of unfolded protein involved in ERAD pathway; regulation of cellular catabolic process; and regulation of transcription, DNA-templated. Acts upstream of or within protein deubiquitination and protein stabilization. Predicted to be located in nucleoplasm. Predicted to be active in cytosol and nucleus. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.